Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis
- PMID: 5501902
Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis
Similar articles
-
Effects of methotrexate on the liver in psoriasis.J Invest Dermatol. 1974 Jun;62(6):597-602. doi: 10.1111/1523-1747.ep12679887. J Invest Dermatol. 1974. PMID: 4835782 No abstract available.
-
Hepatotoxicity of long-term methotrexate therapy for psoriasis.Arch Intern Med. 1973 Sep;132(3):391-6. Arch Intern Med. 1973. PMID: 4783020 No abstract available.
-
Hepatotoxicity of methotrexate in the treatment of psoriasis.Practitioner. 1973 Sep;211(263):324-8. Practitioner. 1973. PMID: 4759241 No abstract available.
-
Drug reactions XV. Methotrexate, psoriasis and the liver.Br J Dermatol. 1971 Sep;85(3):302-5. doi: 10.1111/j.1365-2133.1971.tb07237.x. Br J Dermatol. 1971. PMID: 4939241 Review. No abstract available.
-
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.J Eur Acad Dermatol Venereol. 2011 Jul;25(7):758-64. doi: 10.1111/j.1468-3083.2010.03932.x. Epub 2010 Dec 29. J Eur Acad Dermatol Venereol. 2011. PMID: 21198946 Review.
Cited by
-
Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.Ann Rheum Dis. 2017 Sep;76(9):1509-1514. doi: 10.1136/annrheumdis-2016-210629. Epub 2017 Mar 23. Ann Rheum Dis. 2017. PMID: 28341765 Free PMC article.
-
Longitudinal assessment of liver stiffness using ARFI technique does not support increased risk of fibrosis in rheumatoid arthritis patients on methotrexate.J Ultrasound. 2025 Jun;28(2):323-329. doi: 10.1007/s40477-023-00843-y. Epub 2024 Jan 16. J Ultrasound. 2025. PMID: 38227146
-
Chemotherapy induced liver abnormalities: an imaging perspective.Clin Mol Hepatol. 2014 Sep;20(3):317-26. doi: 10.3350/cmh.2014.20.3.317. Clin Mol Hepatol. 2014. PMID: 25320738 Free PMC article.
-
Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.Dig Dis Sci. 1985 Feb;30(2):104-9. doi: 10.1007/BF01308193. Dig Dis Sci. 1985. PMID: 3967557
-
Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.Br Med J. 1972 Mar 11;1(5801):654-6. doi: 10.1136/bmj.1.5801.654. Br Med J. 1972. PMID: 5015292 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources